188 related articles for article (PubMed ID: 35588018)
1. Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming.
Umar S; Palasiewicz K; Meyer A; Kumar P; Prabhakar BS; Volin MV; Rahat R; Al-Awqati M; Chang HJ; Zomorrodi RK; Rehman J; Shahrara S
Cell Mol Life Sci; 2022 May; 79(6):301. PubMed ID: 35588018
[TBL] [Abstract][Full Text] [Related]
2. IRAK4 inhibitor mitigates joint inflammation by rebalancing metabolism malfunction in RA macrophages and fibroblasts.
Umar S; Palasiewicz K; Volin MV; Zanotti B; Al-Awqati M; Sweiss N; Shahrara S
Life Sci; 2021 Dec; 287():120114. PubMed ID: 34732329
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
Front Immunol; 2021; 12():683800. PubMed ID: 34248968
[TBL] [Abstract][Full Text] [Related]
4. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
[TBL] [Abstract][Full Text] [Related]
5. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
[No Abstract] [Full Text] [Related]
6. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
Palasiewicz K; Umar S; Romay B; Zomorrodi RK; Shahrara S
Eur J Immunol; 2021 Sep; 51(9):2330-2340. PubMed ID: 34107055
[TBL] [Abstract][Full Text] [Related]
7. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
8. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril).
Barhoumi T; Alghanem B; Shaibah H; Mansour FA; Alamri HS; Akiel MA; Alroqi F; Boudjelal M
Front Immunol; 2021; 12():728896. PubMed ID: 34616396
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway.
Khan S; Shafiei MS; Longoria C; Schoggins JW; Savani RC; Zaki H
Elife; 2021 Dec; 10():. PubMed ID: 34866574
[TBL] [Abstract][Full Text] [Related]
11. IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion.
Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Amin MA; Zomorrodi RK; Arami S; Gonzalez M; Rao V; Zanotti B; Fox DA; Sweiss N; Shahrara S
Cell Mol Immunol; 2021 Sep; 18(9):2199-2210. PubMed ID: 32415262
[TBL] [Abstract][Full Text] [Related]
12. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
Bejoy J; Williams CI; Cole HJ; Manzoor S; Davoodi P; Battaile JI; Kaushik A; Nikolaienko SI; Brelidze TI; Gychka SG; Suzuki YJ
Arch Biochem Biophys; 2023 Oct; 748():109769. PubMed ID: 37769892
[TBL] [Abstract][Full Text] [Related]
13. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
14. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
Zhou Y; Wang M; Li Y; Wang P; Zhao P; Yang Z; Wang S; Zhang L; Li Z; Jia K; Zhong C; Li N; Yu Y; Hou J
Immunol Lett; 2021 Sep; 237():33-41. PubMed ID: 34228987
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) attenuates SARS-CoV2 spike protein-induced interleukin-6 and interleukin-8 production in alveolar epithelial cells through activation of Mas receptor.
Shen YL; Hsieh YA; Hu PW; Lo PC; Hsiao YH; Ko HK; Lin FC; Huang CW; Su KC; Perng DW
J Microbiol Immunol Infect; 2023 Dec; 56(6):1147-1157. PubMed ID: 37802686
[TBL] [Abstract][Full Text] [Related]
19. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
Patra T; Meyer K; Geerling L; Isbell TS; Hoft DF; Brien J; Pinto AK; Ray RB; Ray R
PLoS Pathog; 2020 Dec; 16(12):e1009128. PubMed ID: 33284859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
